Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Feb;63(2):123–129. doi: 10.1136/ard.2002.001826

Hepatic manifestations of autoimmune rheumatic diseases

S Abraham 1, S Begum 1, D Isenberg 1
PMCID: PMC1754901  PMID: 14722198

Full Text

The Full Text of this article is available as a PDF (180.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón-Segovia D., Díaz-Jouanen E., Fishbein E. Features of Sjögren's syndrome in primary biliary cirrhosis. Ann Intern Med. 1973 Jul;79(1):31–36. doi: 10.7326/0003-4819-79-1-31. [DOI] [PubMed] [Google Scholar]
  2. Averbuch M., Levo Y. Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant. Ann Rheum Dis. 1986 May;45(5):435–437. doi: 10.1136/ard.45.5.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BARTHOLOMEW L. G., CAIN J. C., WINKELMANN R. K., BAGGENSTOSS A. H. CHRONIC DISEASE OF THE LIVER ASSOCIATED WITH SYSTEMIC SCLERODERMA. Am J Dig Dis. 1964 Jan;9:43–55. doi: 10.1007/BF02232678. [DOI] [PubMed] [Google Scholar]
  4. BARTHOLOMEW L. G., CAIN J. C., WOOLNER L. B., UTZ D. C., FERRIS D. O. Sclerosing cholangitis: its possible association with Riedel's struma and fibrous retroperitonitis. Report of two cases. N Engl J Med. 1963 Jul 4;269:8–12. doi: 10.1056/NEJM196307042690102. [DOI] [PubMed] [Google Scholar]
  5. Beck P. R. Butanol extraction of serum and urinary gamma-glutamyltransferase and its application in clinical diagnosis. Ann Clin Biochem. 1978 May;15(3):151–156. doi: 10.1177/000456327801500131. [DOI] [PubMed] [Google Scholar]
  6. Bernstein M. L., Salusinsky-Sternbach M., Bellefleur M., Esseltine D. W. Thrombotic and hemorrhagic complications in children with the lupus anticoagulant. Am J Dis Child. 1984 Dec;138(12):1132–1135. doi: 10.1001/archpedi.1984.02140500038014. [DOI] [PubMed] [Google Scholar]
  7. Bernstein R. M., Callender M. E., Neuberger J. M., Hughes G. R., Williams R. Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis. 1982 Dec;41(6):612–614. doi: 10.1136/ard.41.6.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Blendis L. M., Ansell I. D., Jones K. L., Hamilton E., Williams R. Liver in Felty's syndrome. Br Med J. 1970 Jan 17;1(5689):131–135. doi: 10.1136/bmj.1.5689.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bradley J. D., Pinals R. S., Gupta R. C. Chronic active hepatitis associated with polymyositis. Association with precipitating mitochondrial M-B antibody. J Rheumatol. 1985 Apr;12(2):368–371. [PubMed] [Google Scholar]
  10. CRISTANSSON J. Corneal changes in a case of hepatitis. Acta Ophthalmol (Copenh) 1954;32(2):161–164. doi: 10.1111/j.1755-3768.1954.tb03313.x. [DOI] [PubMed] [Google Scholar]
  11. Cervera R., Asherson R. A., Lie J. T. Clinicopathologic correlations of the antiphospholipid syndrome. Semin Arthritis Rheum. 1995 Feb;24(4):262–272. doi: 10.1016/s0049-0172(95)80036-0. [DOI] [PubMed] [Google Scholar]
  12. Chwalińska-Sadowska H., Milewski B., Nazarewicz T. Clinical and immunomorphological evaluation of pathological changes in the liver in collagenoses. Mater Med Pol. 1976;8(4):421–428. [PubMed] [Google Scholar]
  13. Cockel R., Kendall M. J., Becker J. F., Hawkins C. F. Serum biochemical values in rheumatoid disease. Ann Rheum Dis. 1971 Mar;30(2):166–170. doi: 10.1136/ard.30.2.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. D'Angelo W. A., Fries J. F., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969 Mar;46(3):428–440. doi: 10.1016/0002-9343(69)90044-8. [DOI] [PubMed] [Google Scholar]
  15. DUBOIS E. L., TUFFANELLI D. L. CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964 Oct 12;190:104–111. doi: 10.1001/jama.1964.03070150014003. [DOI] [PubMed] [Google Scholar]
  16. Dhand A. K., LaBrecque D. R., Metzger J. Sulindac (Clinoril) hepatitis. Gastroenterology. 1981 Mar;80(3):585–586. [PubMed] [Google Scholar]
  17. Elias M., Eldor A. Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. Arch Intern Med. 1984 Mar;144(3):510–515. [PubMed] [Google Scholar]
  18. Esteban J. I., Esteban R., Viladomiu L., López-Talavera J. C., González A., Hernández J. M., Roget M., Vargas V., Genescà J., Buti M. Hepatitis C virus antibodies among risk groups in Spain. Lancet. 1989 Aug 5;2(8658):294–297. doi: 10.1016/s0140-6736(89)90485-6. [DOI] [PubMed] [Google Scholar]
  19. Estes D., Christian C. L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971 Mar;50(2):85–95. doi: 10.1097/00005792-197103000-00001. [DOI] [PubMed] [Google Scholar]
  20. Fraile G., Rodríguez-García J. L., Moreno A. Primary sclerosing cholangitis associated with systemic sclerosis. Postgrad Med J. 1991 Feb;67(784):189–192. doi: 10.1136/pgmj.67.784.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. García-Carrasco M., Ramos M., Cervera R., Font J., Vidal J., Muñoz F. J., Miret C., Espinosa G., Ingelmo M. Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis. 1997 Mar;56(3):173–175. doi: 10.1136/ard.56.3.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gibson T., Myers A. R. Subclinical liver disease in systemic lupus erythematosus. J Rheumatol. 1981 Sep-Oct;8(5):752–759. [PubMed] [Google Scholar]
  23. Golding P. L., Bown R., Mason A. M., Taylor E. "Sicca complex" in liver disease. Br Med J. 1970 Nov 7;4(5731):340–342. doi: 10.1136/bmj.4.5731.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Haddad J., Deny P., Munz-Gotheil C., Ambrosini J. C., Trinchet J. C., Pateron D., Mal F., Callard P., Beaugrand M. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet. 1992 Feb 8;339(8789):321–323. doi: 10.1016/0140-6736(92)91645-O. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hansen B. U., Lindgren S., Eriksson S., Henricsson V., Larsson A., Manthorpe R., Warfvinge G. Clinical and immunological features of Sjögren's syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis. Acta Med Scand. 1988;224(6):611–619. doi: 10.1111/j.0954-6820.1988.tb19634.x. [DOI] [PubMed] [Google Scholar]
  26. Hoyumpa A. M., Jr, Greene H. L., Dunn G. D., Schenker S. Fatty liver: biochemical and clinical considerations. Am J Dig Dis. 1975 Dec;20(12):1142–1170. doi: 10.1007/BF01070758. [DOI] [PubMed] [Google Scholar]
  27. JESSAR R. A., LAMONT-HAVERS R. W., RAGAN C. Natural history of lupus erythematosus disseminatus. Ann Intern Med. 1953 Apr;38(4):717–731. doi: 10.7326/0003-4819-38-4-717. [DOI] [PubMed] [Google Scholar]
  28. KOFMAN S., JOHNSON G. C., ZIMMERMAN H. J. Apparent hepatic dysfunction in lupus erythematosus. AMA Arch Intern Med. 1955 May;95(5):669–676. doi: 10.1001/archinte.1955.00250110039005. [DOI] [PubMed] [Google Scholar]
  29. Kallenberg C. G., Pastoor G. W., Wouda A. A., The T. H. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis. 1982 Aug;41(4):382–387. doi: 10.1136/ard.41.4.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Klofkorn R. W., Steigerwald J. C., Mills D. M., Smyth C. J. Esophageal varices in Felty's syndrome: A case report and review of the literature. Arthritis Rheum. 1976 Mar-Apr;19(2):150–154. doi: 10.1002/art.1780190204. [DOI] [PubMed] [Google Scholar]
  31. LEFKOVITS A. M., FARROW I. J. The liver in rheumatoid arthritis. Ann Rheum Dis. 1955 Jun;14(2):162–169. doi: 10.1136/ard.14.2.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Law I. P., Knight H. Jaundice associated with naproxen. N Engl J Med. 1976 Nov 18;295(21):1201–1201. doi: 10.1056/NEJM197611182952119. [DOI] [PubMed] [Google Scholar]
  33. LeRoy E. C. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest. 1974 Oct;54(4):880–889. doi: 10.1172/JCI107827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lindgren S., Manthorpe R., Eriksson S. Autoimmune liver disease in patients with primary Sjögren's syndrome. J Hepatol. 1994 Mar;20(3):354–358. doi: 10.1016/s0168-8278(94)80007-3. [DOI] [PubMed] [Google Scholar]
  35. Lurie B., Novis B., Bank S., Silber W., Botha J. B., Marks I. N. CRST syndrome and nodular transformation of the liver. A case report. Gastroenterology. 1973 Mar;64(3):457–461. [PubMed] [Google Scholar]
  36. MACKAY I. R., TAFT L. I., COWLING D. C. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet. 1959 Jan 10;1(7063):65–69. doi: 10.1016/s0140-6736(59)91136-5. [DOI] [PubMed] [Google Scholar]
  37. Mackworth-Young C. G., Melia W. M., Harris E. N., Gharavi A. E., Sivathondan Y., Derue G., Sherlock S., Hughes G. R. The Budd-Chiari syndrome. Possible pathogenetic role of anti-phospholipid antibodies. J Hepatol. 1986;3(1):83–86. doi: 10.1016/s0168-8278(86)80150-7. [DOI] [PubMed] [Google Scholar]
  38. Makinen D., Fritzler M., Davis P., Sherlock S. Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum. 1983 Jul;26(7):914–917. doi: 10.1002/art.1780260714. [DOI] [PubMed] [Google Scholar]
  39. Manthorpe R., Permin H., Tage-Jensen U. Auto-antibodies in Sjögren's syndrome. With special reference to liver-cell membrane antibody (LMA). Scand J Rheumatol. 1979;8(3):168–172. doi: 10.3109/03009747909114450. [DOI] [PubMed] [Google Scholar]
  40. McCarty G. A., Rice J. R., Bembe M. L., Barada F. A., Jr Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants. Arthritis Rheum. 1983 Jan;26(1):1–7. doi: 10.1002/art.1780260101. [DOI] [PubMed] [Google Scholar]
  41. McMahon R. F., Babbs C., Warnes T. W. Nodular regenerative hyperplasia of the liver, CREST syndrome and primary biliary cirrhosis: an overlap syndrome? Gut. 1989 Oct;30(10):1430–1433. doi: 10.1136/gut.30.10.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Miller M. H., Urowitz M. B., Gladman D. D., Blendis L. M. The liver in systemic lupus erythematosus. Q J Med. 1984 Summer;53(211):401–409. [PubMed] [Google Scholar]
  43. Mills P. R., MacSween R. N., Dick W. C., More I. A., Watkinson G. Liver disease in rheumatoid arthritis. Scott Med J. 1980 Jan;25(1):18–22. doi: 10.1177/003693308002500104. [DOI] [PubMed] [Google Scholar]
  44. Murray-Lyon I. M., Thompson R. P., Ansell I. D., Williams R. Scleroderma and primary biliary cirrhosis. Br Med J. 1970 Aug 1;3(5717):258–259. doi: 10.1136/bmj.3.5717.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. O'Brien S. T., Eddy W. M., Krawitt E. L. Primary biliary cirrhosis associated with scleroderma. Gastroenterology. 1972 Jan;62(1):118–121. [PubMed] [Google Scholar]
  46. Perez-Ruiz F., Zea-Mendoza A. C. Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies. J Clin Gastroenterol. 1998 Jul;27(1):90–91. doi: 10.1097/00004836-199807000-00021. [DOI] [PubMed] [Google Scholar]
  47. Pomeroy C., Knodell R. G., Swaim W. R., Arneson P., Mahowald M. L. Budd-Chiari syndrome in a patient with the lupus anticoagulant. Gastroenterology. 1984 Jan;86(1):158–161. [PubMed] [Google Scholar]
  48. Powell F. C., Schroeter A. L., Dickson E. R. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med. 1987 Jan;62(237):75–82. [PubMed] [Google Scholar]
  49. Rau R., Pfenninger K., Boni A. Proceedings: Liver function tests and liver biopsies in patients with rheumatoid arthritis. Ann Rheum Dis. 1975 Apr;34(2):198–199. doi: 10.1136/ard.34.2.198-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Roudot-Thoraval F., Gouault-Heilmann M., Zafrani E. S., Barge J., Dhumeaux D. Budd-Chiari syndrome and the lupus anticoagulant. Gastroenterology. 1985 Feb;88(2):605–605. doi: 10.1016/0016-5085(85)90557-8. [DOI] [PubMed] [Google Scholar]
  51. Runyon B. A., LaBrecque D. R., Anuras S. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. Am J Med. 1980 Aug;69(2):187–194. doi: 10.1016/0002-9343(80)90378-2. [DOI] [PubMed] [Google Scholar]
  52. Satoh T., Hirakata M., Yoshida T., Matsumura M., Miyachi K., Mimori T., Akizuki M. Systemic lupus erythmatosus associated with autoimmune hepatitis two cases with novel autoantibodies to transfer RNA-related antigens. Clin Rheumatol. 1997 May;16(3):305–309. doi: 10.1007/BF02238968. [DOI] [PubMed] [Google Scholar]
  53. Seaman W. E., Ishak K. G., Plotz P. H. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med. 1974 Jan;80(1):1–8. doi: 10.7326/0003-4819-80-1-1. [DOI] [PubMed] [Google Scholar]
  54. Seibold J. R., Trontell M. C. Anticentromere antibody and primary pulmonary hypertension. J Rheumatol. 1982 Jul-Aug;9(4):607–609. [PubMed] [Google Scholar]
  55. Shoji I., Takagi T., Kasukawa R. Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis. Intern Med. 1992 Dec;31(12):1348–1355. doi: 10.2169/internalmedicine.31.1348. [DOI] [PubMed] [Google Scholar]
  56. Sienknecht C. W., Urowitz M. B., Pruzanski W., Stein H. B. Felty's syndrome. Clinical and serological analysis of 34 cases. Ann Rheum Dis. 1977 Dec;36(6):500–507. doi: 10.1136/ard.36.6.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Skopouli F. N., Barbatis C., Moutsopoulos H. M. Liver involvement in primary Sjögren's syndrome. Br J Rheumatol. 1994 Aug;33(8):745–748. doi: 10.1093/rheumatology/33.8.745. [DOI] [PubMed] [Google Scholar]
  58. Stennet D. J., Simonson W., Hall C. A. Fenoprofen-induced hepatotoxicity. Am J Hosp Pharm. 1978 Aug;35(8):901–901. [PubMed] [Google Scholar]
  59. TUFFANELLI D. L., WINKELMANN R. K. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol. 1961 Sep;84:359–371. doi: 10.1001/archderm.1961.01580150005001. [DOI] [PubMed] [Google Scholar]
  60. Travers R. L., Hughes G. R. Salicylate hepatotoxicity in systemic lupus erythematosus: a common occurrence? Br Med J. 1978 Dec 2;2(6151):1532–1533. doi: 10.1136/bmj.2.6151.1532-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Van Steenbergen W., Beyls J., Vermylen J., Fevery J., Marchal G., Desmet V., De Groote J. 'Lupus' anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome). Report of three patients and review of the literature. J Hepatol. 1986;3(1):87–94. doi: 10.1016/s0168-8278(86)80151-9. [DOI] [PubMed] [Google Scholar]
  62. Vermylen J., Blockmans D., Spitz B., Deckmyn H. Thrombosis and immune disorders. Clin Haematol. 1986 May;15(2):393–412. [PubMed] [Google Scholar]
  63. Vogel C., Wittenborg A., Reichart P. The involvement of the liver in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol. 1980 Jul;50(1):26–29. doi: 10.1016/0030-4220(80)90326-6. [DOI] [PubMed] [Google Scholar]
  64. Webb J., Whaley K., MacSween R. N., Nuki G., Dick W. C., Buchanan W. W. Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis. 1975 Feb;34(1):70–81. doi: 10.1136/ard.34.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Whaley K., Goudie R. B., Williamson J., Nuki G., Dick W. C., Buchanan W. W. Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet. 1970 Apr 25;1(7652):861–863. doi: 10.1016/s0140-6736(70)91690-9. [DOI] [PubMed] [Google Scholar]
  66. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES